[2026] HKCFI 3827Court of First Instance14 Jul 2026Judicial Review / Public Law
Boill Healthcare Holdings Ltd, listed on the Main Board since 2013, saw trading in its shares suspended on 25 July 2024 after conflicting announcements about the composition of its Board (§7). The dispute pitted Mr Qiu Dongfang, the original single largest beneficial shareholder, against Mr He Yu, who held Mr Qiu's shares pledged as security for a loan (§7). The Company was given an 18-month remedial period, expiring 24 January 2026, to satisfy eight Resumption Guidance items, but failed to do so. The Listing Committee cancelled the listing under Rule 6.01A(1) on 13 February 2026 (§16), and the Listing Review Committee ("LRC") upheld that decision on 12 May 2026 (§21). The Company then sought leave to apply for judicial review.